Producers, Others Say Aussie PBS Still Not Covering Cost-Effective Drugs
This article was originally published in PharmAsia News
Executive Summary
Drug makers and Australian patient groups are pressuring the nation’s Pharmaceutical Benefits Scheme to fulfill a promise made nearly a year ago to resume automatic coverage of drugs forecast to cost the scheme less than U.S.$10.5 million year.